Viatris makes generic and off-patent branded drugs.
Viatris Inc. (VTRS) is expected to report earnings on Thursday, November 5, 2026, before the open. Estimated release time 07:53 ET. Consensus EPS estimate is $0.64.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-06 | Jun 2026 qtr | $0.60 | $0.69 | +14.8% | $3.76B |
| 2026-05-07 | Mar 2026 qtr | $0.50 | $0.59 | — | $3.52B |
| 2026-02-26 | Dec 2025 qtr | $0.53 | $0.57 | +7.1% | $3.70B |
| 2025-11-06 | Sep 2025 qtr | $0.62 | $0.67 | +7.9% | $3.76B |
| 2025-08-07 | Jun 2025 qtr | $0.56 | $0.62 | +11.5% | $3.58B |
| 2025-05-08 | Mar 2025 qtr | $0.49 | $0.50 | +1.6% | $3.25B |
| 2025-02-27 | Dec 2024 qtr | $0.61 | $0.54 | -11.5% | $3.53B |
| 2024-11-07 | Sep 2024 qtr | $0.68 | $0.75 | +10.8% | $3.74B |
VTRS has beaten consensus EPS in 6 of its last 7 scored quarters.
See VTRS on the live calendar →